Matrix metalloproteinases exhibit different expression patterns in inflammatory demyelinating diseases of the central and peripheral nervous system

Annals of the New York Academy of Sciences

Volumn 878, Issue , 1999, Pages 567-570

  Kieseier, B C ^a   Clements, J M ^b   Gearing, A J H ^b   Hartung, H P ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b British Biotech Pharmaceuticals Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MATRILYSIN; MATRIX METALLOPROTEINASE; MESSENGER RNA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; CONTROLLED STUDY; DEMYELINATING DISEASE; NEURITIS; NONHUMAN; PERIPHERAL NERVOUS SYSTEM;

ANIMALIA;

EID: 0032816370     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07729.x     Document Type: Conference Paper

References (5)

1. 1. Gijbels, K. et al. 1994. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteinases. J. Clin. Invest. 94: 2177-2182.
2. 2. Hewson, A.K. et al. 1995. Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790. Inflamm. Res. 44: 345-349.
3. 3. Kieseier, B.C. et al. 1998. Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis. Brain 121: 159-166.
4. 4. Hughes, P.M. et al. 1998. Matrix metalloproteinase expression during experimental autoimmune neuritis. Brain 121: 481-494.
5. 5. Kieseier, B.C. et al. 1998. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré Syndrome. Ann. Neurol. 43: 427-434.